methylprednisolone has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azimi, AR; Farhadi Shabestari, HR; Ghadiri, F; Jamali, R; Namaei, P; Vahabizad, F | 1 |
| Agrawal, B; Karam, D; Purohit, P; Swiatkowski, S | 1 |
2 other study(ies) available for methylprednisolone and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Evaluation of liver injury in multiple sclerosis patients receiving pulsed steroid therapy.
Topics: Alcoholism; Humans; Methylprednisolone; Multiple Sclerosis; Non-alcoholic Fatty Liver Disease | 2022 |
High-dose steroids as a therapeutic option in the management of spur cell haemolytic anaemia.
Topics: Acute Kidney Injury; Aged; Anemia, Hemolytic, Autoimmune; Dizziness; Glucocorticoids; Humans; Liver Diseases; Male; Methylprednisolone; Non-alcoholic Fatty Liver Disease; Steroids; Treatment Outcome | 2018 |